Santa Clara, CA, United States of America

Preeti G Lal

Average Co-Inventor Count = 3.7

ph-index = 13

Forward Citations = 798(Granted Patents)

Forward Citations (Not Self Cited) = 777(Sep 21, 2024)

DiyaCoin DiyaCoin 0.60 

Inventors with similar research interests:


Location History:

  • Sunnyvale, CA (US) (1998 - 2005)
  • Santa Clara, CA (US) (1998 - 2014)
  • Burlingame, CA (US) (2014 - 2018)


Years Active: 1998-2018

where 'Filed Patents' based on already Granted Patents

209 patents (USPTO):

Title: Preeti Lal: Innovating for Medical Advancements

Introduction:

Preeti Lal, a renowned inventor and scientist, hails from Sunnyvale, CA in the United States. With an impressive record of 164 patents, Lal is a leading figure in the field of medical research and innovation. His groundbreaking inventions and contributions to the medical industry have had a profound impact on numerous disorders associated with gene expression. Let's delve into his latest patents, career highlights, and collaborations that have shaped his remarkable journey.

Latest Patents:

1. Prostate associated Ets protein (PRAEP):

Lal's invention introduces a human prostate associated Ets protein (PRAEP) and its corresponding polynucleotides that identify and encode PRAEP. This breakthrough has opened up new possibilities for the treatment and prevention of disorders associated with the expression of PRAEP. In addition, the invention provides a range of essential components such as expression vectors, host cells, antibodies, agonists, and antagonists that further enhance the application of PRAEP in medical research.

2. Two new human DnaJ-like proteins (HSPJ1 or HSPJ2):

Lal's second notable invention involves two new human DnaJ-like proteins (HSPJ1 or HSPJ2) and the corresponding polynucleotides. These proteins have immense potential in treating disorders associated with their expression. Just like his previous patent, this invention also includes expression vectors, host cells, agonists, antibodies, and antagonists to amplify the practicality and effectiveness of HSPJ1 or HSPJ2.

Career Highlights:

Preeti Lal has flourished in his career, with notable stints at renowned companies such as Incyte Pharmaceuticals, Inc. and Incyte Genomics, Inc. Incyte Pharmaceuticals, Inc., a pioneering pharmaceutical company, has provided Lal with the opportunity to turn his innovative ideas into tangible products that have contributed significantly to the medical field. His work at Incyte Genomics, Inc., a company focused on advancing genome research, has further solidified his standing as a leading figure in the industry.

Collaborations:

Throughout his career, Lal has collaborated with exceptional individuals who share his passion for medical innovation. Notably, he has worked closely with Neil C Corley and Olga Bandman, both esteemed experts in their respective fields. These collaborations have fostered an environment of knowledge exchange, leading to fresh insights, inspired ideas, and breakthrough inventions that have impacted the medical community.

Conclusion:

Preeti Lal's impressive number of patents, including his recent breakthroughs in the medical field, emphasizes his dedication to advancing healthcare through innovation. His inventions, such as the prostate-associated Ets protein (PRAEP) and the two new human DnaJ-like proteins (HSPJ1 or HSPJ2), have opened up new avenues in the treatment and prevention of associated disorders. With his notable career highlights and valuable collaborations, Lal continues to make significant contributions to medical advancements that positively impact countless lives worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…